CN110575472A - Spray with anti-inflammatory, analgesic and blood circulation promoting effects - Google Patents
Spray with anti-inflammatory, analgesic and blood circulation promoting effects Download PDFInfo
- Publication number
- CN110575472A CN110575472A CN201910966358.2A CN201910966358A CN110575472A CN 110575472 A CN110575472 A CN 110575472A CN 201910966358 A CN201910966358 A CN 201910966358A CN 110575472 A CN110575472 A CN 110575472A
- Authority
- CN
- China
- Prior art keywords
- parts
- spray
- blood circulation
- root
- diminishing inflammation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007921 spray Substances 0.000 title claims abstract description 25
- 230000017531 blood circulation Effects 0.000 title claims abstract description 17
- 230000001737 promoting effect Effects 0.000 title claims abstract description 12
- 230000003110 anti-inflammatory effect Effects 0.000 title description 7
- 230000001760 anti-analgesic effect Effects 0.000 title description 5
- 206010061218 Inflammation Diseases 0.000 claims abstract description 29
- 230000004054 inflammatory process Effects 0.000 claims abstract description 28
- 208000002193 Pain Diseases 0.000 claims abstract description 25
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 16
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 16
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 16
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 16
- 241000123069 Ocyurus chrysurus Species 0.000 claims abstract description 16
- 229940116229 borneol Drugs 0.000 claims abstract description 16
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 16
- 230000003467 diminishing effect Effects 0.000 claims abstract description 16
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 16
- 241000195954 Lycopodium clavatum Species 0.000 claims abstract description 10
- 239000002904 solvent Substances 0.000 claims abstract description 10
- 230000003213 activating effect Effects 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 230000000694 effects Effects 0.000 claims description 19
- 239000003814 drug Substances 0.000 claims description 13
- 244000025254 Cannabis sativa Species 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 241000173529 Aconitum napellus Species 0.000 claims description 3
- 230000000857 drug effect Effects 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 238000005325 percolation Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 230000006870 function Effects 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 208000006820 Arthralgia Diseases 0.000 abstract description 4
- 208000034656 Contusions Diseases 0.000 abstract description 3
- 206010024453 Ligament sprain Diseases 0.000 abstract description 3
- 208000000112 Myalgia Diseases 0.000 abstract description 3
- 208000010040 Sprains and Strains Diseases 0.000 abstract description 3
- 230000009519 contusion Effects 0.000 abstract description 3
- 230000001476 alcoholic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000003973 paint Substances 0.000 description 6
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000003908 liver function Effects 0.000 description 3
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 229940124599 anti-inflammatory drug Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000004665 defense response Effects 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000035657 Abasia Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a spray with the functions of diminishing inflammation, easing pain and promoting blood circulation. The spray with the functions of diminishing inflammation, easing pain and promoting blood circulation comprises the following components in parts by weight: 10-20 parts of lycopodium clavatum root; 15-20 parts of madder; 10-15 parts of radix aconiti; 3-5 parts of safflower; 20-30 parts of borneol. Mixing the raw materials, percolating with ethanol to obtain alcoholic solution, decocting to obtain concentrated mixture, mixing the two solutions, concentrating, adding appropriate amount of solvent, and making into spray. The spray with the functions of diminishing inflammation, easing pain and activating blood circulation provided by the invention can treat related diseases such as indication sprain, contusion, arthralgia and myalgia.
Description
Technical Field
The invention relates to the field of medicines, in particular to a spray with the functions of diminishing inflammation, easing pain and promoting blood circulation.
Background
Inflammation is what is commonly called "inflammation" and is a defense response of the body to stimuli, manifested by redness, swelling, heat, pain, and dysfunction. The inflammation may be infectious inflammation caused by infection or non-infectious inflammation not caused by infection. Normally, inflammation is beneficial and an automatic defense response of the human body, but sometimes, inflammation is also harmful, such as attack on the body's own tissues, inflammation occurring in transparent tissues, and the like.
In order to prevent inflammation diffusion, anti-inflammatory and analgesic drugs are often required to be taken, the drugs generally have slow effect, certain side effects exist in human bodies after being taken, certain skin inflammations are often accompanied with bleeding, and the common anti-inflammatory and analgesic drugs do not directly act on inflammation parts and cannot stop bleeding quickly, so that the anti-inflammatory and analgesic effects are poor.
Disclosure of Invention
Aiming at the defects in the prior art, the spray with the effects of diminishing inflammation, easing pain and activating blood provided by the invention solves the technical problems, and provides the spray with the effects of diminishing inflammation, easing pain and activating blood and treating related diseases such as indication sprain, contusion, arthralgia and myalgia and the like.
in order to achieve the purpose, the invention provides the following technical scheme:
A spray with anti-inflammatory, analgesic and blood circulation promoting effects comprises the following components in parts by weight: 10-20 parts of lycopodium clavatum root; 15-20 parts of madder; 10-15 parts of radix aconiti; 3-5 parts of safflower; 20-30 parts of borneol.
The paint comprises the following components in parts by weight: 10 parts of buck grass root; 15 parts of madder; 10 parts of radix aconiti; 3 parts of safflower; 23 parts of borneol.
The paint comprises the following components in parts by weight: 20 parts of buck grass root; 20 parts of madder; 14 parts of radix aconiti; 5 parts of safflower; 30 parts of borneol.
The paint comprises the following components in parts by weight: 15 parts of lycopodium clavatum root; 17 parts of madder; 12 parts of radix aconiti; 4 parts of safflower; 24 parts of borneol.
A preparation method of a spray with the functions of diminishing inflammation, easing pain and promoting blood circulation comprises the following steps:
A. mixing the raw materials of the root of common clubmoss herb, the India madder root, the common monkshood mother root, the safflower and the borneol uniformly;
B. Filtering the mixed materials by alcohol percolation to obtain alcohol solution component;
C. Then the mixed raw materials in the step B are decocted to obtain a solution;
D. Mixing and filtering the solutions obtained in the step B and the step C, and concentrating the solution by industrial equipment to obtain a concentrated solution;
E. The concentrated solution is added with a proper amount of solvent to prepare a spray for use.
wherein, the solvent is an auxiliary solvent which can improve the drug effect of the concentrated solution and accords with the national drug production standard.
The invention has the beneficial effects that: the spray with the functions of diminishing inflammation, easing pain and activating blood provided by the invention directly acts on inflammation parts, and has good anti-inflammation and analgesic effects and quick response; the spray also has the function of promoting blood circulation, thereby relieving the harm and pain caused by inflammation and treating related diseases such as indication sprain, contusion, arthralgia, myalgia and the like.
For a better understanding of the features and technical content of the present invention, refer to the following detailed description of the invention.
Detailed Description
to further illustrate the technical means adopted by the present invention and the effects thereof, the following detailed description is given with reference to the preferred embodiments of the present invention.
a spray with anti-inflammatory, analgesic and blood circulation promoting effects comprises the following components in parts by weight: 10-20 parts of lycopodium clavatum root; 15-20 parts of madder; 10-15 parts of radix aconiti; 3-5 parts of safflower; 20-30 parts of borneol.
Further, the paint comprises the following components in parts by weight: 10 parts of buck grass root; 15 parts of madder; 10 parts of radix aconiti; 3 parts of safflower; 23 parts of borneol.
further, the paint comprises the following components in parts by weight: 20 parts of buck grass root; 20 parts of madder; 14 parts of radix aconiti; 5 parts of safflower; 30 parts of borneol.
further, the paint comprises the following components in parts by weight: 15 parts of lycopodium clavatum root; 17 parts of madder; 12 parts of radix aconiti; 4 parts of safflower; 24 parts of borneol.
A preparation method of a spray with the functions of diminishing inflammation, easing pain and promoting blood circulation comprises the following steps:
A. Mixing the raw materials of the root of common clubmoss herb, the India madder root, the common monkshood mother root, the safflower and the borneol uniformly;
B. Filtering the mixed materials by alcohol percolation to obtain alcohol solution component;
C. Then the mixed raw materials in the step B are decocted to obtain a solution;
D. mixing and filtering the solutions obtained in the step B and the step C, and concentrating the solution by industrial equipment to obtain a concentrated solution;
E. the concentrated solution is added with a proper amount of solvent to prepare a spray for use.
Furthermore, the solvent is an auxiliary solvent which can improve the drug effect of the concentrated solution and accords with the national drug production standard.
the spray provided by the invention can be used for treating inflammation diminishing, pain easing and blood activating, in order to further verify the curative effect of the prescription on patients, treatment tracking records are carried out on 100 cases with joint swelling and pain, the average age of the patients is 30-70 years, the average course of disease is 4.5 years, the patients are divided into mild, moderate and severe, and mild patients walk normally and particularly have slight pain feeling in rainy days; moderate patients have obvious pain feeling when walking normally, especially in rainy days; severe patients are essentially unable to walk normally. The prescription is used for treatment, the specific method is rubbing, three times a day, and massage is carried out for half an hour after rubbing, the treatment effect is shown in table 1 for patients with different degrees, and the obvious effect refers to a case that the effect is obvious and the pain is eliminated within 7 days after the medicine is taken; effective refers to the case that the effect is remarkable and the pain is eliminated within 14 days, and the ineffective refers to the case that the effect is basically not realized and the pain cannot be eliminated within 30 days; recovery refers to a case with remarkable effect within 7 days and no relapse within 180 days.
TABLE 1 therapeutic data of patients with different degrees of swelling and pain of joints using the drug of the present invention
| Degree of | Recovery method | Show effect | is effective | Invalidation | Total up to | High efficiency |
| Mild degree of | 20 | 29 | 8 | 3 | 60 | 95.0％ |
| of moderate degree | 6 | 12 | 4 | 3 | 25 | 88.0％ |
| Severe degree | 3 | 5 | 4 | 3 | 15 | 80.0％ |
In order to further verify the safety of the prescription, simultaneously, the medicine treatment contrast tracking record is carried out on another batch of patients, 100 patients are also selected, the average age of the patients is 30-70 years, the average course of disease is 4.5 years, the treatment group adopts the medicine administration treatment, the contrast group adopts the general pain-relieving medicine administration treatment, the medicine is periodically administered, the liver function examination is periodically carried out, the contrast treatment result proves that the liver function examination of the treatment group adopting the medicine is normal, the transaminase suddenly rises, and the state of the patients is stable; the patients who adopt the control administration have the phenomenon of transaminase rise in liver function detection, and simultaneously have the phenomenon of vertigo and vomit of some patients, thereby proving the safety of the use of the medicine.
The above description is only for the specific embodiments of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention, and all the changes or substitutions should be covered within the scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.
Claims (6)
1. The spray with the effects of diminishing inflammation, easing pain and activating blood circulation is characterized by comprising the following components in parts by weight: 10-20 parts of lycopodium clavatum root; 15-20 parts of madder; 10-15 parts of radix aconiti; 3-5 parts of safflower; 20-30 parts of borneol.
2. The spray with the effects of diminishing inflammation, easing pain and activating blood circulation as claimed in claim 1 is characterized by comprising the following components in parts by weight: 10 parts of buck grass root; 15 parts of madder; 10 parts of radix aconiti; 3 parts of safflower; 23 parts of borneol.
3. The spray with the effects of diminishing inflammation, easing pain and activating blood circulation as claimed in claim 1 is characterized by comprising the following components in parts by weight: 20 parts of buck grass root; 20 parts of madder; 14 parts of radix aconiti; 5 parts of safflower; 30 parts of borneol.
4. The spray with the effects of diminishing inflammation, easing pain and activating blood circulation as claimed in claim 1 is characterized by comprising the following components in parts by weight: 15 parts of lycopodium clavatum root; 17 parts of madder; 12 parts of radix aconiti; 4 parts of safflower; 24 parts of borneol.
5. The preparation method of the spray with the effects of diminishing inflammation, easing pain and promoting blood circulation as claimed in claim 1, is characterized by comprising the following steps:
A. mixing the raw materials of the root of common clubmoss herb, the India madder root, the common monkshood mother root, the safflower and the borneol uniformly;
B. Filtering the mixed materials by alcohol percolation to obtain alcohol solution component;
C. Then the mixed raw materials in the step B are decocted to obtain a solution;
D. mixing and filtering the solutions obtained in the step B and the step C, and concentrating the solution by industrial equipment to obtain a concentrated solution;
E. The concentrated solution is added with a proper amount of solvent to prepare a spray for use.
6. The spray with the effects of diminishing inflammation, easing pain and promoting blood circulation as claimed in claim 5, wherein the solvent is an auxiliary solvent which can improve the drug effect of the concentrated solution and meets the national drug production standard.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910966358.2A CN110575472A (en) | 2019-10-11 | 2019-10-11 | Spray with anti-inflammatory, analgesic and blood circulation promoting effects |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910966358.2A CN110575472A (en) | 2019-10-11 | 2019-10-11 | Spray with anti-inflammatory, analgesic and blood circulation promoting effects |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110575472A true CN110575472A (en) | 2019-12-17 |
Family
ID=68814496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910966358.2A Pending CN110575472A (en) | 2019-10-11 | 2019-10-11 | Spray with anti-inflammatory, analgesic and blood circulation promoting effects |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110575472A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101301339A (en) * | 2008-06-20 | 2008-11-12 | 牛天卓 | Babu far infrared medicinal plaster for treating arthralgia and myalgia, and wind-cold syndrome and numbness |
| CN103230430A (en) * | 2013-04-07 | 2013-08-07 | 广东恒诚制药有限公司 | Traditional Chinese medicine gel cream for treating lumbar disc herniation |
| CN105748625A (en) * | 2016-03-30 | 2016-07-13 | 青岛百瑞吉生物工程有限公司 | Pain-relieving liniment high in stability and preparation method |
-
2019
- 2019-10-11 CN CN201910966358.2A patent/CN110575472A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101301339A (en) * | 2008-06-20 | 2008-11-12 | 牛天卓 | Babu far infrared medicinal plaster for treating arthralgia and myalgia, and wind-cold syndrome and numbness |
| CN103230430A (en) * | 2013-04-07 | 2013-08-07 | 广东恒诚制药有限公司 | Traditional Chinese medicine gel cream for treating lumbar disc herniation |
| CN105748625A (en) * | 2016-03-30 | 2016-07-13 | 青岛百瑞吉生物工程有限公司 | Pain-relieving liniment high in stability and preparation method |
Non-Patent Citations (2)
| Title |
|---|
| 刘远军，等: "复方威灵仙酊的制备与应用", 中国医院药学杂志, vol. 22, no. 02, pages 113 * |
| 鲁寒: "散瘀止痛膏治疗急性踝扭伤200例", 实用中医内科杂志, vol. 21, no. 03, pages 99 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104922289A (en) | Joint pain relieving gel and preparation method thereof | |
| CN109223860A (en) | A kind of compound five-element grass spray | |
| CN102861128A (en) | Application of effective site of salvianolic acids to preparation of preparations for treating skin diseases | |
| CN104306402B (en) | A kind of Chinese medicine composition for treating burn and scald infection and preparation method thereof | |
| CN103768388A (en) | Traditional Chinese medicine formula for treating scalds, burns and trauma by being singly applied externally | |
| CN110575472A (en) | Spray with anti-inflammatory, analgesic and blood circulation promoting effects | |
| CN101983652A (en) | Traditional Chinese medicine for treating scapulohumeral periarthritis | |
| CN108434227A (en) | A kind of drug for treating tinea pedis | |
| CN103055069A (en) | External Chinese medicine composition for treating postherpetic neuralgia and preparation method of composition | |
| CN103520289B (en) | A kind of Chinese medicine composition for the treatment of constipation and its preparation method and application | |
| CN113730341A (en) | Bitong gel and using method and preparation method thereof | |
| CN1994457B (en) | Swelling-relieving pain-stopping externally applied ointment | |
| CN105055800A (en) | Plant compound gel for treating chloasma and preparation method thereof | |
| CN101336990B (en) | Medicine for treating cholecystitis | |
| CN103251720B (en) | Plaster for treating facial paralysis | |
| CN110876770B (en) | Traditional Chinese medicine spray for treating plaster allergy and preparation method | |
| CN111166803B (en) | Pure traditional Chinese medicine mask for relieving rash related to tumor-targeted medicine and preparation method thereof | |
| CN102357201B (en) | Traditional Chinese medicine composition for treating venous injury, and preparation method and application thereof | |
| CN113244363B (en) | Traditional Chinese medicine cake moxibustion for orthopedics department as well as preparation method and application thereof | |
| CN103157053A (en) | Pain-relieving traditional Chinese medicine preparation and preparation method thereof | |
| CN1887317B (en) | Externally applied liniment for treating rheumatic and rheumatoid arthritis and its preparation | |
| CN105497077A (en) | Ointment for treating herpes zoster | |
| CN105560837A (en) | Drug for treating skin injuries and preparation method thereof | |
| CN1453031A (en) | Externally-applied medicine composition for treating mastoproliferation and its prepn | |
| CN1994404A (en) | Chinese medicinal pill for treating lumbar and leg pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |